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The function of the Vibrio 7th pandemic island-1
(VSP-1) in cholera pathogenesis has remained
obscure. Utilizing chromatin immunoprecipitation
sequencing and RNA sequencing to map the regulon
of the master virulence regulator ToxT, we identify
a TCP island-encoded small RNA that reduces the
expression of a previously unrecognized VSP-1-
encoded transcription factor termed VspR. VspR
modulates the expression of several VSP-1 genes
including one that encodes a novel class of di-
nucleotide cyclase (DncV), which preferentially syn-
thesizes a previously undescribed hybrid cyclic
AMP-GMP molecule. We show that DncV is required
for efficient intestinal colonization and downregu-
latesV. cholerae chemotaxis, a phenotype previously
associated with hyperinfectivity. This pathway cou-
ples the actions of previously disparate genomic
islands, defines VSP-1 as a pathogenicity island in
V. cholerae, and implicates its occurrence in 7th
pandemic strains as a benefit for host adapta-
tion through the production of a regulatory cyclic
di-nucleotide.
INTRODUCTION
The causative agent of cholera, Vibrio cholerae, requires a multi-
faceted regulatory network involving a hierarchy of transcription
factors, small RNAs (sRNAs), and signaling molecules to ensure
the proper spatial and temporal activation of virulence factor
expression (Ritchie and Waldor, 2009). Often referred to as the
master virulence regulator, ToxT directly activates expression
of several essential virulence genes including those that encode
cholera toxin and an essential colonization factor, the toxin cor-
egulated pilus (TCP) (Lowden et al., 2010). Although ToxT is
essential for V. cholerae pathogenesis, the complete spectrum
of genes it regulates is unknown (DiRita et al., 1991; Weber
and Klose, 2011).358 Cell 149, 358–370, April 13, 2012 ª2012 Elsevier Inc.ToxT is encoded on the TCP island, a chromosomal segment
that encodes many virulence-associated genes found in all
pandemic strains of V. cholerae (Faruque and Mekalanos,
2003). All pandemic strains also carry the CTX prophage encod-
ing the genes for cholera toxin (ctxAB) as well as the genomes for
satellite phages (Hassan et al., 2010). Two V. cholerae biotypes
account for the majority of all recorded cholera pandemics.
The classical biotype is thought to have caused the first six
pandemics (Kaper et al., 1995; Pollitzer, 1959) but was replaced
by the 7th pandemic El Tor biotype approximately 50 years ago
(Faruque and Mekalanos, 2003). 7th pandemic El Tor strains
are genetically distinguishable from classical strains by the pres-
ence of two genomic islands, Vibrio 7th pandemic island-1
(VSP-1) and VSP-2 (Dziejman et al., 2002). These islands are con-
sistently found in clinical El Tor isolates and are thought to be
responsible, at least in part, for the success of the 7th pandemic
clone (Dziejman et al., 2002; Grim et al., 2010; Rahman et al.,
2008; Taviani et al., 2010). However, validation of predicted func-
tions for most open reading frames (ORFs) on these islands or
evidence for the contribution of VSP-1 or VSP-2 to environmental
or host adaptation is lacking (Dziejman et al., 2002). Furthermore,
it is unknown how VSP-1 and VSP-2 genes are regulated and
whether their products act as isolated modules or integrate
into pathways with the ancestral genome or accessory-encoded
elements such as the TCP island and CTX prophage.
Cyclic di-nucleotides act as intracellular signals, modulating
a range of cellular activities (Gomelsky, 2011). In Gram-negative
bacteria, cyclic di-GMP (c-di-GMP) is a major regulator of bio-
films (Tischler and Camilli, 2004) and flagellum biosynthesis
(Lim et al., 2007). Coordination between c-di-GMP and tran-
scription was clearly shown in V. cholerae where c-di-GMP
directly binds to and modulates the activity of transcriptional
regulator VpsT (Krasteva et al., 2010) and upregulates another
virulence regulator AphA (Srivastava et al., 2011). Gram-positive
bacteria also produce cyclic di-AMP (c-di-AMP). Listeria mono-
cytogenes secretes c-di-AMP, which serves as a recognition
signal for the mammalian innate immune system (Woodward
et al., 2010), and Staphylococcus aureus uses c-di-AMP to
manage cell membrane stress (Corrigan et al., 2011). Surpris-
ingly, cyclic di-nucleotides other than c-di-GMP have not been
reported in Gram-negative bacteria including V. cholerae.
Table 1. ChIP-Seq and RNA-Seq Identify ToxT Genomic Binding Locations and Transcriptional Effects on Associated Genes in
V. cholerae
Gene ID Gene Symbol Expression Fold Change pToxT/pBADa
ChIP Peak Coordinatesb
50 Range 30 Range
VC0819 aldA-1c 25.4 876,617–876,658 877,119–877,227
VC0820 tagAc 9.6
VC0821 4.9
VC0822 4.4
VC0823 4.4
VC0824 tagD 5.5
VC0825 tcpIc 26.7 888,017–888,176 889,300–889,465
VC0826 tcpPc 11.4
VC0827 tcpH 14.2
VC0828 tcpAc 121.0 889,949–890,042 890,629–890,743
VC0829 tcpB 83.5
VC0830 tcpQ 130.0
VC0831 tcpC 77.4
VC0832 tcpR 50.2
VC0833 tcpD 19.4
VC0834 tcpS 18.3
VC0835 tcpT 45.2
VC0836 tcpE 42.7
VC0837 tcpF 14.5
VC0838 toxT 1092.8
VC0839 tcpJ 35.7
VC0841 acfC 10.7
VC0842 10.4
VC0843 tagE-1 19.3
VC0844 acfAc 11.8 906,114–906,155 906,501–906,548
VC0845 acfDc 12.2
VC1456 ctxB 14.6
VC1457 ctxAc 39.7 1,567,651–1,567,778 1,568,622–1,568,768
Intergenic VC0845–VC0846 — — 910,838–910,977 911,831–911,899
aFold expression change for each gene determined by RNA-seq from three independent samples: FDR corrected p < 0.001.
bThe location of ToxT peaks was determined from four independent samples (FDR < 0.001). The range of the 50 and 30 end coordinate is shown. A ChIP
peak is associated with a gene if it overlaps the start codon.
cGenes with previously identified/predicted ToxT-binding sites in their promoter regions are shown.Here, we use massively parallel DNA-sequencing technolo-
gies to identify the complete regulon of ToxT. Combining tran-
scriptome profiling (RNA sequencing [seq]) with binding location
analysis (chromatin immunoprecipitation sequencing [ChIP-
seq]), we identify all genes directly regulated by ToxT in vivo as
well as several indirectly regulated pathways. From this analysis
we identified a TCP-encoded sRNA that downregulates expres-
sion of a novel VSP-1 encoded transcription factor, which in
turn controls the expression of several VSP-1 genes including
one that is required for efficient intestinal colonization by
V. cholerae. We show that the gene product that stimulates
intestinal colonization encodes a di-nucleotide cyclase (DncV)
that preferentially synthesizes a hybrid cyclic AMP-GMP mole-
cule. Furthermore, the activity of this enzyme strongly influences
the chemotactic behavior of V. cholerae, thereby associating theaction of this enzyme with a process known to influence infec-
tivity and the intestinal colonization process.
RESULTS
ToxT Directly Activates Genes Only within the TCP
Island and CTX Prophage and Indirectly Regulates
Several Other Metabolic Pathways
ToxT expression increases 500–1,000-fold when V. cholerae
colonizes a mammalian host (Mandlik et al., 2011). To simulate
this expression change, we cloned ToxT into a plasmid under
the control of an inducible promoter in V. cholerae El Tor strain
C6706, an isolate from the 7th pandemic that extended into Peru
in 1991 (Mandlik et al., 2011). Using this system, we increased
ToxT expression 1,000-fold following induction (Table 1). WeCell 149, 358–370, April 13, 2012 ª2012 Elsevier Inc. 359
Figure 1. The ToxT Regulon
(A) Schematic outlining ToxT regulon. Major regulatory targets grouped by functional class are shown. Solid arrows denote direct ToxT regulation identified by
integrated ChIP-seq and RNA-seq analysis. Dashed arrows denote indirect ToxT regulation identified by RNA-seq alone. Green indicates positive gene
expression; red indicates negative gene expression. Specific pathways are indicated beside their functional group and colored to indicate the direction of their
regulation.
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previously described a method to perform ChIP in combination
with massively parallel sequencing (ChIP-seq) to identify
genome-wide binding locations of transcription factors in
V. cholerae (Davies et al., 2011). Applying this method, we identi-
fied all ToxT-binding locations (ChIP peaks) in the V. cholerae
genome under our test conditions (Figure 1A; Table 1).
From each ChIP-seq run we aligned an average of 1.4 million
short 36 base reads to the published N16961 V. cholerae
genome (Heidelberg et al., 2000). The alignments gave a total
average coverage of 13-fold for chromosome 1 and 8-fold
coverage of chromosome 2. This depth of coverage allowed us
to use a low false discovery rate (FDR) cutoff of 0.001% to call
ToxT ChIP peaks. ChIP peaks are called when the sequence
coverage of a given genomic region in the experimental sample
exceeds the control sample at a rate specified by the FDR (see
Experimental Procedures). We compared the peak lists gener-
ated from four samples and set a limit that a peak must be
called in all experiments to be considered a ToxT-binding site
(Ha˚ndstad et al., 2011). We then associated a ToxT peak with
a gene if the peak overlapped the first codon of the respective
gene (Figure 1A; Table 1).
To validate ToxT transcriptional control of associated genes,
we briefly induced ToxT expression (10 min), isolated and
sequenced total mRNA (RNA-seq), and compared the transcrip-
tome profile to a control strain carrying an empty expression
vector. We reasoned that direct regulatory targets of ToxT would
show the most rapid transcriptional response to brief ToxT
induction. Comparison of the transcriptome response with our
ChIP-seq analysis uniformly showed strong transcriptional
upregulation of the same genes we had associated with ToxT
ChIP peaks, supporting our conclusion that these genes are
directly activated by ToxT (Figure 1A; Table 1). These results
provide the first detailed in vivo map of ToxT-binding locations
in conjunction with ToxT-driven expression alteration.
A ToxT-binding motif (Toxbox) has been previously proposed
based on the sequences of all known ToxT-binding sites (Withey
andDiRita, 2006). This Toxbox consensusmatches to thousands
of potential sites across the V. cholerae genome. Thus, we were
surprised when our analysis identified only six ToxT ChIP peaks
(Table 1). Interestingly, all ToxT ChIP peaks are located in the
TCP island and CTX prophage. Importantly, five of the six ChIP
peaks we identified overlap all ToxT-binding sites previously
identified by direct in vitro ToxT footprinting assays or inferred
from genetic analysis (Richard et al., 2010; Withey and DiRita,
2005a, 2005b, 2006), validating our technique to identify(B) Schematic of the 6th ToxT ChIP peak site in the Tcp island between VC0845 a
ChIP peak. Below, alignment of RNA-seq reads shows the predicted sRNA outline
genome, whereas reads colored green align to the forward strand. The predicted
nucleotides in bold highlight a rho-independent hairpin terminator predicted by t
(C) ToxT ChIP enrichment of the promoter regions of ctxA, tcpA, and 6th ToxT Ch
a non-ToxT-dependent promoter of VC1141 is shown as a control. Significan
****p < 0.0001. Mean with standard error of the mean (SEM) is shown.
(D) Northern blot of RNA from indicated strains probed for the presence of the sR
a ssRNA ladder are indicated. The same samples were probed for 5S rRNA as a
(E) qPCR analysis of the effect of TarB on VC0177 (VspR) expression levels in
a plasmid. Expression for each sample was determined relative to 16S rRNA, and
relative to expression in the WT strain. Significance was determined by t test rel
See also Table S1.authentic ToxT-binding locations. Three ToxT ChIP peaks lay
between divergently transcribed gene pairs aldA-1/tagA, tcpI/
tcpP, and acfA/acfD. Each of these genes is known to have its
own associated ToxT-binding motif(s) (Richard et al., 2010;
Withey and DiRita, 2005a, 2005b, 2006); however, resolving
closely spaced binding sites using ChIP-seq is challenging and
often results in one overlapping ChIP peak. The confinement of
ToxT binding to the TCP island and CTX prophage, despite
its predicted statistically common consensus binding motif,
suggests that factors in addition to nucleotide sequence may
influence the stringency of DNAbinding selection by ToxT in vivo.
We also identified several additional genes not directly associ-
ated with ToxT ChIP peaks that were differentially regulated
following ToxT induction (Figure 1; see Table S1 available online).
These genes encode components of pathways involved in iron
transport, amino acid metabolism, transcriptional regulation,
pilus assembly, and carbon transport and metabolism (Figure 1).
Interestingly, whereas direct regulatory targets of ToxT were
strongly upregulated, the majority of these indirectly regulated
genes were downregulated. Among the pathways impacted,
iron transport exhibited the largest concerted effect with 19
genes downregulated >5-fold (Figure 1; Table S1). This includes
pathways for the production of vibriobactin, hemin, and iron III
transporters as well as TonB, a protein that supports transport.
Conversely, the largest upregulation was from genes involved
in maltose transport (Figure 1A; Table S1). Specifically, the
maltose ABC transporter and the maltoporin (ompS) all showed
increased expression >12-fold (Table S1). It is unclear how ToxT
indirectly impacts the expression of these genes. ToxT does
directly increase expression of the transcription factor TcpP
encoded by the TCP island; thus, it is possible that TcpP directly
affects some genes including the eight additional transcription
factors indirectly affected by ToxT (Figure 1A; Table 1). TcpP
and these transcriptional regulators may drive changes ob-
served in the ToxT transcriptome profile.
ToxT Directly Regulates the Expression of the TCP
Island-Encoded sRNA TarB
We identified a 6th ToxT ChIP peak located in an intergenic
region of the Tcp island between genes VC0845 and VC0846
(Figure 1B). Quantitative PCR (qPCR) validated our sequencing
data showing that the enrichment of ToxT ChIP DNA at this inter-
genic site was similar to that of ToxT-binding sites upstream of
ctxA and tcpP (Figure 1C). Alignment of RNA-seq reads from
ToxT expressing V. cholerae with the region between VC0845nd VC0846. The heat map shows enrichment (red) of sequenced reads at ToxT
d by the black box. RNA-seq reads colored red align to the reverse strand of the
sequence of the sRNA is shown at the top in uppercase font from 50 to 30. The
he ARNold program server.
IP peak was determined by qPCR relative to sample DNA input. Enrichment of
ce was determined by t test relative to the VC1141 promoter: ***p < 0.001;
NA (TarB) as predicted by RNA-seq alignment (top panel). The size markers of
loading control (bottom panel).
V. cholerae WT strains C6706 and E7946 following expression of ToxT from
at least three independent replicates were tested. Fold changes are normalized
ative to the WT strain: **p < 0.01; ****p < 0.0001. Mean with SEM is shown.
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and VC0846 revealed a putative sRNA on the reverse strand
overlapping the new ToxT-binding site (Figure 1B). The sRNA
had a clear 50 start at coordinate 911308 and appeared to termi-
nate at coordinate 911239 following a predicated rho-indepen-
dent hairpin terminator (Figure 1B). Northern blotting using
a probe against this region identified a sRNA that was strongly
induced by ToxT (Figure 1D). The sRNA migrated slightly below
the 80 nucleotide (nt) ssRNA marker agreeing with the 69 nt size
predicted from RNA-seq read alignments. An identical sRNA has
recently been identified (Bradley et al., 2011), and thus, we called
this sRNA ToxT-activated sRNA B (TarB). TarB has also been
shown to be strongly upregulated in V. cholerae during infection
of an animal model (Mandlik et al., 2011).
TarB Represses the Expression of a V. cholerae VSP-1
Gene
The small regulatory protein Hfq binds sRNAs, stabilizing and
assisting them for targeting and promoting degradation of
specific mRNAs (Brennan and Link, 2007). TarB levels were
greatly decreased in a V. cholerae C6706 hfq::Tn mutant (Fig-
ure 1D), suggesting that TarB likely interacts with Hfq and thus
may help to negatively regulate target mRNAs. We reasoned
that if TarB negatively regulated a gene, the expression of the
target gene should be higher in a DtarB strain compared to the
wild-type (WT) when ToxT is expressed. We took a genetic
approach to identify potential mRNA targets of TarB by using
RNA-seq to compare the expression profiles of WT and DtarB
strains expressing ToxT. We identified only two genes, VC0177
and VC2706, as having significantly increased expression
levels in the DtarB strain, suggesting that expression of TarB
may decrease their stability (VC0177 expression DtarB/WT =
21.5-fold, p < 1e5; VC2706 expression DtarB/WT = 4.5-fold,
p < 1e5). Interestingly, the most strongly upregulated gene in
the DtarB mutant, VC0177, is part of VSP-1. qPCR confirmed
the RNA-seq analysis showing that VC0177 expression was
significantly higher in the DtarB strain than the WT (Figure 1E).
We also showed that this pathway was active in a second clinical
El Tor strain, E7946 (Figure 1E). This indicates that the ToxT-
TarB-VC0177 pathway is not strain specific. However, TarB
does appear to have a more profound effect on VC0177 in strain
C6706 compared to E7946, suggesting some variability in the
magnitude of the effect of this pathway in different strains.
The interaction between TarB and VSP-1 encoded VC0177 is
reminiscent of the coordinated control of the TCP island and
prophage CTXF. Both VSP-1 and prophage CTXF are acquired
horizontally and separately from the TCP island, yet genes from
both VSP-1 and phage CTXF are ultimately regulated by TCP
island-encoded ToxT. VC0177 expression formally joins the
ToxT regulon through its dependence on ToxT-regulated TarB
induction. This association suggests that the co-occurrence of
at least VSP-1 in 7th pandemic strains of V. cholerae may have
been driven by its regulatory integration with other accessory
elements (TCP and CTX) encoding pathogenic adaptation.
VC0177 Is a Transcription Factor that Represses
Several VSP-1 Genes
Annotated as a hypothetical protein, VC0177 does not share
sequence homology with known proteins by basic alignment362 Cell 149, 358–370, April 13, 2012 ª2012 Elsevier Inc.searches (BLAST). However, HHPRED analysis (Biegert et al.,
2006), which uses protein structure prediction, indicates that
VC0177 shares structural homology with metallo-regulator re-
pressor proteins. Because ToxT directly regulates genes located
predominantly in the island in which it is encoded, we reasoned
that VC0177 might have similar restrictions and repress genes
within VSP-1, which spans loci VC0175–VC0185. Agreeing
with the predicted transcription repressor role for VC0177, we
found that expression of four VSP-1 genes was significantly
increased in a VC0177::Tn mutant (Figure 2A). Furthermore, we
found that the expression of the same four genes was similarly
affected in strains carrying an in-frame deletion of VC0177, indi-
cating that the regulation control was not due to the transposon
insertion (Figure S1A).
To test whether VC0177 was directly involved in the regulation
of these genes, we performedChIPwith VC0177 and assayed for
enrichment in regions directly upstream of VC0177-repressed
genes by qPCR. We identified enrichment of 50 untranslated
regions (UTRs) directly upstream of VC0176, VC0178, VC0179,
and VC0180, supporting a direct role for VC0177 as a transcrip-
tional repressor of these genes (Figure 2B). Therefore, we called
the product of VC0177 the V. cholerae 7th pandemic regulator
(VspR).
The TarB Regulatory Circuit and VSP-1 ORF VC0179
Influence V. cholerae Intestinal Colonization
To determine if the TarB-VspR regulatory circuit is involved in
pathogenesis, we used the infant mouse model to measure
V. cholerae intestinal colonization. To our knowledge, the effect
of genes in VSP-1 on intestinal colonization has not been inves-
tigated. We found that the V. cholerae C6706 DtarB mutant
showed a significant decrease in ability to colonize the small
intestine compared to the WT strain in competition assays
(Figure 2C).
Combining the DtarB deletion with a VC0177::Tn mutant
rescued the DtarB-dependent colonization defect (Figure 2C).
This suggests that TarB likely influences colonization by
downregulation of the VC0177-encoded regulator VspR.
Because expression of VC0178, VC0179, and VC0180 increased
in the V. cholerae VC0177::Tn mutant strain, we tested
V. cholerae transposon mutants disrupted in these genes for
intestinal colonization defects. Remarkably, only disruption of
VC0179 caused a significant defect in intestinal colonization
(Figure 2C). An in-frame deletion mutant of VC0179 (DVC0179)
also showed a similar in vivo colonization defect (Figure 2C).
These results identify VC0179 as a direct target of VspR repres-
sion in VSP-1 and, thus, an indirect target of TarB-mediated
induction.
TarB is well conserved among all sequenced strains of
V. cholerae including the classical strain O395 even though
classical strains lack VSP-1 and therefore lack VspR. Northern
blots show that ToxT also induces TarB in an O395 strain (Fig-
ure 1D); however, we did not anticipate a critical in vivo role for
TarBO395 due to the lack of VSP-1. Agreeing with this, we found
that deletion of TarB does not affect O395 colonization of the
infant mouse intestine in competition assays (Figure 2C). TarB
may regulate additional genes in O395 strains that do not
influence intestinal colonization.
Figure 2. VSP-1 Integration in Virulence
(A) Expression analysis of VSP-1 genes in WT and VC0177::Tn C6706 strains.
The expression of each gene was determined relative to total 16S rRNA. Eight
replicates were sampled for each gene. Significance was determined by t test:
*p < 0.05; **p < 0.01; ****p < 0.0001. Mean with SEM is shown.
(B) VC0177 (VspR) ChIP enrichment of the 50 UTRs of VC0176, VC0178,
VC0179, and VC0180 was determined by qPCR relative to sample DNA input.
Enrichment of the promoter region of non-VSP-1 gene VC1141 is shown as
a control. Significance was determined by t test relative to control enrichment:
*p < 0.05; **p < 0.01. Mean with SEM is shown.
(C) In vivo competition experiments measuring the ability of mutant strains to
colonize the infant mouse intestine compared to the parental strain. Signifi-During the preparation of this manuscript, another group pub-
lished the presence of TarB in a different El Tor strain, E7946, as
part of a genome-wide study identifying ToxT-induced sRNAs
(Bradley et al., 2011). Although agreeing with our observation,
Bradley et al. also reported a variable colonization phenotype
for aDtarBmutant in strain E7946 that depended on initial growth
conditions of the bacterium. We found a consistent intestinal
colonization defect of an E7946 DtarB mutant with our growth
conditions (Figure 2C). This defect was less severe than in strain
C6706, which may be due to the difference in downregulation of
VspR by TarB between these strains (Figure 1E). Using a compu-
tational approach to identify TarB mRNA targets, Bradley et al.
reported an 2-fold repression of colonization factor TcpF
mRNA. The authors noted that repression of a colonization
factor by a ToxT-activated sRNA was counterintuitive. In
contrast we did not detect an effect on TcpF expression in our
genetic approach to identify TarB targets but did show that
TarB downregulates VspR expression 12-fold in strain E7946,
indicating that the ToxT-TarB-VspR pathway is active in E7946
and not specific to strain C6706 (Figure 1E). Computational
prediction indicates that TarB has amore favorable and a simpler
base-pairing configuration with the 50 UTR of VspR than TcpF,
providing an explanation as to why TarB regulates VspR more
strongly (Figures S1B and S1C).
VC0179 Is the First Member of a New Family
of Di-Nucleotide Cyclases
Disruption of VSP-1 encoded VC0179 caused a significant
defect in intestinal colonization (Figure 2C). VC0179 is a hypo-
thetical protein and does not share overall sequence homology
with known proteins. HHPRED analysis shows that VC0179
shares spatial alignment of key active site residues found
in 20-50-oligoadenylate synthetases (OAS1) and poly(A) poly-
merase, both of which are part of the nucleotidyl transferase
superfamily (NTS) (Holm and Sander, 1995) (Figure S2). The
placement of these active site residues in VC0179 matches the
consensus sequence (G[G/S]x9–13Dx[D/E]) of the NTS (Holm
and Sander, 1995). OAS1 and poly(A) polymerase catalyze the
polymerization of oligoadenylates from ATP (Hartmann et al.,
2003). The structural similarity with OAS1 and poly(A) poly-
merase suggested that VC0179 might act catalytically on ATP.
To test this hypothesis, we purified VC0179, incubated it with
a-P32 ATP, and separated the products on a denaturing poly-
acrylamide gel. VC0179 produced a single product that migrated
slightly above theATPprecursor (Figure 3A). As a control, wemu-
tated the aspartate residues of the predicted VC0179 Dx[D/E]
catalytic center to alanine residues (D131A and D133A; Fig-
ure S2) and purified the mutant protein. When incubated with
ATP, the D131A/D133A VC0179 mutant protein did not produce
the VC0179 product from ATP (Figure 3A), indicating that activity
from the WT protein is dependent upon the predicted NTS cata-
lytic residues and is not due to a contaminate.
The product produced from ATP by VC0179 is insensitive to
calf intestinal phosphatase (CIP), indicating that it does notcance was determined by t test relative to colonization ratio of parental strains
WT C6706 versus C6706 DlacZ: ****p < 0.0001.
See also Figure S1.
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Figure 3. Di-Nucleotide Cyclase Activity of VC0179
(A) PurifiedWT or mutated VC0179 was incubated with 1 mM ATP and 10 mCi a-P32 ATP for the indicated time (t in min), and the products (P1) were separated by
denaturing PAGE.
(B) The product from the reaction between VC0179 and ATP (P1) was incubated with CIP or snake venom phosphodiesterase (SVPD) for 30min and separated by
denaturing PAGE.
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contain 50 or 30 terminal phosphate groups (Figure 3B). The pro-
duct is sensitive to snake venom phosphodiesterase and
nuclease P1, indicating that it contains 30-50 phosphate linkages
(Figure 3B; data not shown). These results suggested that the
VC0179 product was a cyclic nucleotide. High-performance
liquid chromatography (HPLC) analysis showed that the
VC0179 product eluted with the same retention time as a
commercial c-di-AMP standard (Figures 3F and 3G). Further-
more, LCMS and MS/MS analysis showed that the VC0179
product and c-di-AMP have identical molecular masses and
fragmentation fingerprint (Tables S2 and S3; Figures S3
and S4), confirming that VC0179 synthesizes c-di-AMP. To our
knowledge, this is the first report of c-di-AMP synthesis
by a Gram-negative bacterium enzyme and the first adenylate
cyclase based on a non-DU147 protein domain structure
(Ro¨mling, 2008).
We tested the catalytic ability of VC0179 with additional
nucleotides. We found that VC0179 is not active against dATP
(data not shown). When incubated with GTP, VC0179 produces
c-di-GMP (Figure 3C) that was confirmed by HPLC, LCMS, and
MS/MS comparison with a commercial c-di-GMP standard
(Figures 3F, 3H, S3, and S4; Tables S2 and S3). Interestingly,
both PAGE and HPLC analysis indicated more c-di-AMP pro-
duction than c-di-GMP per unit time, suggesting that VC0179
synthesized c-di-AMP more efficiently than c-di-GMP. Prior to
these results, only proteins containing GGDEF domains were
thought to be able to produce c-di-GMP in bacteria (Ryjenkov
et al., 2005). We also tested whether VC0179 could enzymati-
cally modify TTP, UTP, and CTP but did not detect significant
activity (data not shown), suggesting that VC0179 preferentially
uses purine nucleotide triphosphates as substrates.
Because VC0179 can use ATP and GTP substrates but
appears to be more efficient in its use of ATP, we asked if it
preferred one substrate to the other when given the option. We
incubated VC0179 with equal molar amounts of GTP and ATP
and analyzed the products by PAGE, HPLC, LCMS, and
MS/MS. Remarkably, we found that the dominant reaction
product migrated between c-di-AMP and c-di-GMP by PAGE
(Figures 3D and 3E). This new product was observed in much
greater amounts than either c-di-AMP or c-di-GMP as confirmed
by HPLC (Figures 3F and 3I). This suggested that VC0179
preferentially synthesizes a hybrid c-AMP-GMP molecule from
ATP and GTP. High-resolution LCMS analysis confirmed that
the mass of the VC0179 reaction product incubated with
ATP and GTP was in agreement with a c-AMP-GMP molecule
(Table S2; Figure S3). MS/MS was used to fragment this product
into masses accurate for AMP and GMP, further confirming
the hybrid structure (Table S3; Figure S4). As with ATP, the(C) Purified WT VC0179 was incubated with 1 mM GTP and 10 mCi a-P32 GTP
denaturing PAGE.
(D) VC0179 was incubatedwith ATP or GTP as described above or with 1mMGTP
PAGE. P1, c-di-AMP; P2, c-di-GMP; P3, c-AMP-GMP.
(E) Purified WT VC0179 was incubated with 1 mM GTP and 10 mCi a-P32 ATP
denaturing PAGE.
(F–J) Commercial standards of ATP, GTP, c-di-AMP, and c-di-GMP were fract
VC0179 incubated with 2 mM ATP (G), 2 mM GTP (H), 1 mM ATP plus 1 mM GTP
RP-HPLC. A total of 50 nM of VC0179 (DncV) WT or mutant enzyme was used p
See also Figures S2, S3, S4, and S5 and Tables S2 and S3.D131A/D133A VC0179 mutant protein did not produce any
product when incubated with GTP or an ATP/GTP mixture
(Figure S5A).
Given that in metabolically active cells there is a mixture of all
NTPs, we tested the preference of VC0179 in a mixture that
included equal amounts of all five NTPs. We again found that
VC0179 produced substantially more of the hybrid c-AMP-
GMP molecule than any other cyclic di-nucleotide (Figure 3J).
To our knowledge, this is the first report of an enzyme that can
produce a hybrid cyclic di-nucleotide and the first enzyme
capable of producing three different cyclic di-nucleotides.
Therefore, we have designated the product of VC0179 di-
nucleotide cyclase Vibrio or DncV. Using BLAST and ClustalW,
we identified and align homologs that were at least 20% similar
to DncV and had the conserved G[G/S]x9–13Dx[D/E] motif
(Figure S5B). DncV homologs can be identified in a wide range
of bacteria, several of which are pathogenic.
c-AMP-GMP Is the Dominate DncV Product In Vivo
Because DncV is capable of synthesizing three different cyclic
di-nucleotides in vitro, we assayed its activity in vivo. We
addressed this question using two systems. We first used
a heterologous system to induce high-level expression of WT
DncV or the D131A/D133A DncV mutant from a plasmid in
E. coli. Analysis of cytosolic samples by LCMS showed a strong
signal for c-AMP-GMP in E. coli expressing WT DncV, but not in
E. coli expressing D131A/D133A DncV mutant (Table 2; Figures
S6A and S6B). We also observed a c-di-AMP signal in E. coli
expressing WT DncV but again not in E. coli expressing
D131A/D133A DncV mutant (Table 2; Figures S6C and S6D).
We observed c-di-GMP in bothWT andmutant DncV expressing
E. coli that most likely represents endogenous production (data
not shown). Thus, we cannot conclude that the c-di-GMP de-
tected in this sample was a product of DncV under this condition.
We next examined cytosolic samples from a V. cholerae
DdncV strain expressing WT DncV or D131A/D133A DncV
mutant from an inducible plasmid. LCMS analysis identified
c-AMP-GMP in the WT DncV-expressing strain, but not in the
D131A/D133A DncV mutant-expressing strain (Table 2; Fig-
ure 4A). Interestingly, we could not detect c-di-AMP or c-di-
GMP in any of the V. cholerae samples. However, we cannot
rule out that DncV does produce c-di-AMP and/or c-di-GMP in
V. cholerae at levels below our detection limit. These results indi-
cate that DncV can synthesize c-AMP-GMPandc-di-AMP in vivo
but that c-AMP-GMP is the major product. Equal amounts of
culture where processed for each sample, and total ion count
analyzed for each sample is shown as an analysis control
(Figures S7A and S7B).for the indicated time (t in min), and the products (P2) were separated by
and 10 mCi a-P32 ATP, and the products (P1–P3) were separated by denaturing
for the indicated time (t in min), and the products (P3) were separated by
ionated by RP-HPLC. The peaks are labeled by their respective compound.
(I), or 1 mM of each of the five NTPs (J) for 30 min at 37C was fractionated by
er reaction.
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Table 2. Expected and Determined Masses of Cyclic Di-
Nucleotides Identified in E. coli and V. cholerae Strains
Expressing WT DncV from LCMS Analysis
Sample
Expected
Mass
Determined
Mass Error (ppm)
E. coli c-AMP-GMP 673.0927 673.0922 0.74
E. coli c-di-AMP 657.0978 657.0972 0.91
V. cholera c-AMP-GMP 673.0927 673.0936 1.34DncV Activity Modulates V. cholerae Chemotaxis
and Does Not Affect c-di-GMP-Dependent Regulation
We did not notice a significant growth difference between
V. cholerae WT and DdncV mutant strains in rich or minimal
medium (data not shown). To determine biological effects of
DncV expression, we used RNA-seq to compare the transcrip-
tome profiles of a DdncV mutant and a DdncV mutant in which
DncV expression was induced from a plasmid for 15 min. From
this analysis we observed coordinated differential expression
of groups of genes that clustered into four biological processes
(Figure 4B; Table S4). The largest concerted regulatory effect
showed that many chemotactic genes downregulated following
DncV induction. Signal-transducing chemotactic proteins are
known to bind purines (Stock et al., 1987), suggesting that the
products of DncV could directly interact and modulate the
activity of these proteins. We tested the chemotactic abilities
of the WT, DdncV mutant, and DdncV mutant expressing DncV
from a plasmid using semisolid agar chemotaxis plates and
found that increased expression of DncV severely inhibited
V. cholerae chemotaxis (Figure 4C). We also found that express-
ing the DncV D131A/D133A mutant did not affect chemotaxis,
indicating that the catalytic activity of DncV is required for this
phenotype (Figure 4C). WT and D131A/D133A mutant proteins
showed similar expression and degradation patterns following
induction, indicating that the observed effects were not due to
a difference in protein level (Figure S7C).
Although we did not observe any changes in the expression of
flagellum biogenesis genes, it is possible that the effect we
observed on the semisolid agar was due to defects in flagellum
biogenesis or function. To test this possibility, we extracted
WT plus vector and DdncV mutant plus pDncV from the plate
containing arabinose shown in Figure 4C and checked for
motility. Phase-contrast microscopy showed that increased ex-
pression of DncV did not change overall motility of V. cholerae,
agreeing with our transcriptome analysis that expression of
flagellum components was unaffected (Movies S1 and S2). Inter-
estingly, repressing chemotaxis has been shown to significantly
enhance V. cholerae intestinal colonization (Butler et al., 2006).
Thus, expression of VC0179 may enhance colonization by sup-
pressing chemotactic behavior.
We compared our transcriptome results to recently published
microarray analysis of the regulatory effects of increased c-di-
GMP production in V. cholerae (Beyhan et al., 2006). The most
prominent regulatory effects of increased c-di-GMP levels in-
cluded increased expression of MSHA, the extracellular protein
secretion system (EPS), and Vibrio polysaccharide (VPS) bio-
genesis genes, as well as decreased expression of flagellum
biogenesis genes. In contrast our transcriptome analysis of366 Cell 149, 358–370, April 13, 2012 ª2012 Elsevier Inc.DncV induction showed decreased expression of MSHA biosyn-
thesis genes, and no effect on EPS, VPS, or flagellum biogenesis
genes (Table S4). Furthermore, increased c-di-GMP levels were
shown to drastically reduce the number of motile bacterium and
increase biofilm production (Beyhan et al., 2006), whereas
expression of DncV does not affect V. cholerae motility (Movies
S1 and S2) or biofilm production (unpublished data). c-AMP-
GMP is the dominant molecule produced by DncV in vivo
(Figures 4A and S6). The lack of gene regulatory and phenotypic
overlap between increased DncV expression and increased
c-di-GMP levels suggests that c-AMP-GMP and c-di-GMP
have different regulatory roles in the cell.
DISCUSSION
The VSP islands are the most pronounced genetic difference
between classical and El tor strains of V. cholerae (Dziejman
et al., 2002); however, any fitness benefit they offered El tor
strains was unknown. Our results describe a multifaceted regu-
latory cascade driven by ToxT and mediated through the TCP
island-encoded sRNA, TarB, that downregulates expression of
VSP-1 transcription factor VspR (Figure 5). Loss of VspR dere-
presses VSP-1 genes, including VC0179, which encodes a novel
di-nucleotide cyclase, DncV, which is required for efficient
V. cholerae intestinal colonization and regulates the coloniza-
tion-influencing process of chemotaxis. DncV is the first reported
enzyme capable of synthesizing c-di-AMP in Gram-negative
bacteria and the first enzyme capable of synthesizing the previ-
ously undescribed hybrid c-AMP-GMP.
It was previously shown that VC0179 expression was upregu-
lated in the rabbit intestine supporting a role for VC0179 in intes-
tinal colonization (Xu et al., 2003). The connection between
induction of themaster virulence regulator ToxT and VSP-1 regu-
lation strongly suggested that genes encoded by VSP-1 were
expressed in vivo and likely contribute to pathogenesis or other
virulence-associated properties (e.g., transmission or infectivity).
The association of VSP-1 with V. cholerae colonization offers
the first evidence that the evolutionary success of V. cholerae
El Tor strains carrying VSP-1 islands may have been driven by
increased fitness within the host and, thus, implies that VSP-1
is indeed a pathogenicity island. It is possible that VSP-1 contrib-
utes to properties that might improve the fitness of 7th pandemic
El Tor strains of V. cholerae in the aquatic environment because
some VSP-1 genes have been recently found in environmental
non-O1, non-O139 V. cholerae strains (Grim et al., 2010). How-
ever, VSP-1 was universally present in TCP+ O1 and O139
strains (Grim et al., 2010; Rahman et al., 2008), suggesting that
the regulatory linkage of the TCP and VSP-1 islands documented
here may be selecting for their coinheritance in pathogenic 7th
pandemic strains.
Comparative genome analysis shows that DncV homologs are
found in pathogenic islands of other disease-causing bacteria
including the High Pathogenicity Island (HPI) of Enterobacteria-
ceae strains (Paauw et al., 2010; Schubert et al., 2004). Interest-
ingly, DncV homologs in HPI are often found associated with the
closely neighboring VSP-1 gene VC0181. VC0181 is annotated
as an integrative and conjugative element, suggesting that it
may help DncV recombine into new genomes and genomic
Figure 4. DncV In Vivo Biochemical and
Regulator Activity
(A) LCMS chromatogram trace corresponding
to the ion extraction of c-AMP-GMP (theoretical
mass [M  H] = 673.0927 Da; ion extrac-
tion: 673.0922–673.0947 m/z) in cell lysate from
V. cholerae DdncV strain expressing plasmid-
borne WT or D131A/D133A mutant DncV. High-
resolution mass found under the peak eluting
at approximately 4.75 min in chromatogram A
corresponding to c-AMP-GMP from V. cholerae
DdncV strain expressing WT DncV is shown in the
inset. This peak eluted with the same retention
time as in vitro-generated c-AMP-GMP.
(B) Functional categories of differentially ex-
pressed genes in response to expression of
DncV. The number of genes induced or repressed
in response to DncV expression is presented.
Green indicates that genes in the respective
category are induced >2-fold; red indicates
that genes in respective category are repressed
>2-fold (FDR corrected p value <0.01).
(C) Examination of chemotactic behavior of
V. choleraeWT,DdncVmutant, andDdncVmutant
expressing WT or D131A/D131A mutant DncV
from an arabinose-inducible plasmid, with and
without induction by arabinose.
See also Figures S6 and S7, Table S4, and Movies
S1 and S2.islands. There are additional VSP-1 genes that did not appear in
our network that may also influence V. cholerae colonization.
These genes might still be regulated by VspR, but our conditions
may not have favored their expression. VspR might also play
a regulator role outside of VSP-1 that future ChIP-seq analysis
will illuminate. The neighboring gene, VC0176, is annotated as
a putative CI/Cro-like regulator. Because VspR appears to affect
VC0176 expression, there may be regulatory interplay between
these two factors that modulates VSP-1 activity or other genes
outside of the island. Further characterization of the hypothetical
proteins encoded in VSP-1 and VSP-2 may offer significantCell 149, 358–3insights into differences into host adapta-
tion of the 7th pandemic El Tor lineage of
V. cholerae.
In bacteria, c-di-GMP is synthesized
by proteins containing a GGDEF motif,
which are found in the majority of bacte-
rial genomes (Ryjenkov et al., 2005).
c-di-AMP is synthesized in Gram-positive
bacteria by proteins containing the un-
related DUF147 domain (Witte et al.,
2008). Remarkably, the active site of
DncV is able to produce both c-di-AMP
and c-di-GMP compounds as well as
a previously undescribed hybrid c-AMP-
GMP. Our initial biochemical analysis
suggests that DncV has a strong product
preference for synthesis of c-AMP-GMP
followed by c-di-AMP and c-di-GMP.
These results agree with our finding thatc-AMP-GMP is the dominant DncV product in vivo. Future struc-
tural analysis of DncV will be particularly interesting to determine
its mode of substrate selection and catalytic action. Although
DncV appears to have a product preference, the balance of
product it produces in vivo would be heavily influenced by its
local intracellular NTP concentration. Energetic shifts that alter
the cytosolic ATP concentration could also impact DncV product
production.
Cyclic nucleotides act as intracellular signals, modulating
a range of cellular activities (Gomelsky, 2011). In Gram-negative
bacteria, c-di-GMP is a major regulator of biofilms (Tischler and70, April 13, 2012 ª2012 Elsevier Inc. 367
Figure 5. Model for ToxT-Dependent TarB-
Mediated Control of VSP-1
(1) Host signals induce ToxT activity resulting in
transcription of TarB from the Tcp Island. (2)
Stabilized by Hfq, TarB downregulates expres-
sion of transcriptional repressor VC0177 (VspR),
resulting in derepression of VSP-1 genes including
VC0179 (DncV). (3) DncV activity increases cellular
concentration of c-AMP-GMP (and possibly c-di-
AMP and c-di-GMP) that affects (4) chemotactic
behavior and other metabolic aspects of 7th
pandemic V. cholerae.Camilli, 2004) and flagellum biosynthesis (Lim et al., 2007), and in
Gram-positive bacteria, c-di-AMP reports on DNA integrity and
cell membrane stress (Corrigan et al., 2011; Woodward et al.,
2010). Because DncV can produce both molecules, its activity
may influence all of these processes. The hybrid c-AMP-GMP
molecule may function in both c-di-GMP and c-di-AMP path-
ways and/or completely new processes specific to a hybrid
interaction. Expression comparison showed that regulatory
events mediated by DncV induction are not likely due to in-
creased c-di-GMP levels. Increased expression of DncV strongly
inhibits V. cholerae chemotaxis, but the bacteria are still highly
motile. Interestingly, V. cholerae shed from humans show
reduced expression of chemotaxis genes (Merrell et al., 2002).
Repression of chemotaxis is thought to contribute to a hyperin-
fectious state of V. cholerae, and indeed, repressing chemotaxis
has been shown to significantly enhance V. cholerae intestinal
colonization (Butler et al., 2006). These observations suggest
a mechanism for the necessity of DncV for efficient V. cholerae
intestinal colonization. We propose that the in vivo environment
induces ToxT activity that in turn results in derepression of
DncV via the TarB-VspR pathway and an inhibition of chemo-
taxis via the accumulation of cyclic di-nucleotides. Reduced
chemotaxis might not only stimulate colonization but also influ-
ence infectivity long after V. cholerae exits the ToxT-inducing
environment of the small intestine (Butler et al., 2006; Merrell
et al., 2002).
Interestingly, DncV expression induced fatty acid catabolism
and repressed fatty acid biosynthesis. Metabolomic analysis of
cecal fluidharvested fromV.cholerae-infected rabbitshas recently
revealed that the intestinalmilieu contains high levels of long-chain
fatty acids compared to laboratory medium (Mandlik et al., 2011).
Fatty acids were recently shown to modulate ToxT activity, and
indeed, a 16-carbon fatty acid cis-palmitoleate crystallizes with
ToxT when expressed and purified from E. coli (Lowden et al.,
2010). It will be interesting to investigate if DncV activity creates
regulatory signals thatmodulateToxTactivity in vivobyspecifically
stimulating the breakdown of host lipids and transport of fatty
acids. However, a role for cyclic di-nucleotides in regulating fatty
acid metabolism has not yet been demonstrated in V. cholerae.
The association of DncV expression with ToxT activity sug-
gests that the cellular concentration of c-di-AMP, c-di-GMP,368 Cell 149, 358–370, April 13, 2012 ª2012 Elsevier Inc.and/or c-AMP-GMP may increase sig-
nificantly when V. cholerae enters the
host intestinal environment. Interestingly,
c-di-AMP has recently been shown to besecreted by multidrug efflux pumps from L. monocytogenes
(Woodward et al., 2010). In the context of L. monocytogenes
infection, c-di-AMP alters the mammalian host immune
response (Woodward et al., 2010), and recently cyclic di-nucle-
otides have been identified as key agonists of the STING innate
immune signaling pathway (Burdette et al., 2011). Purinergic
receptors known to modulate pH and electrolyte secretion are
found extensively on the apical membrane of intestinal epithelial
cells where V. cholerae colonizes (Dho et al., 1992; Kaunitz and
Akiba, 2011). We are currently investigating whether V. cholerae
may also secrete c-AMP-GMP and/or c-di-AMP as these cyclic
di-nucleotides could interact with the host cell receptors to
modulate intestinal cell electrophysiology or innate immunity.
Such an effect could be beneficial to a range of intestinal patho-
gens that carry DncV homologs. Thus, secreted c-AMP-GMP
and/or c-di-AMP could act as bacterial toxins that affect disease
progression. The discovery of DncV-produced cyclic di-nucleo-
tides adds another layer of complexity to V. cholerae pathogen-
esis and implicates these novel small molecules in the disease
process.
EXPERIMENTAL PROCEDURES
ChIP-Seq and RNA-Seq
ChIP, sample preparation, sequencing, and data processing were performed
as previously described by Davies et al. (2011). Experiments were repeated in
quadruplicate. Samples were sequenced using the HeliScope Single Molecule
Sequencer at the Molecular Biology Core Facility in the Dana-Farber Cancer
Institute.
For ToxT expression studies RNA was converted to cDNA, and subsequent
sample preparation and sequencing were performed as described for ChIP-
seq. For VC0179 expression studies RNA sampleswere processed for Illumina
multiplex sequencing as described by the manufacturer. Sequencing data
were aligned to the V. cholerae N16961 genome using CLC genomic work-
bench software using RPKM for expression values. The statistical test
performed was a Baggerley’s test on proportion of counts in each group of
samples to generate a p value associated with the weighted proportion fold
change between experiment and control groups for each gene. The result is
a weighted t-type test statistic. We then used a cutoff of 4-fold weighted
proportion absolute change with a FDR corrected p value of%0.01.
RP-HPLC, LCMS, and LC-MS/MS
Reverse-phase HPLC (RP-HPLC) was performed as previously described by
Oppenheimer-Shaanan et al. (2011). High-resolution LCMS analysis was
performed on an Agilent 6520 Accurate-Mass Q-TOF mass spectrometer
using an electrospray (ESI) ionization source in negative mode. Tandem
MS/MS analysis was performed using collision-induced dissociation (CID).
Ions were selected using a medium iso width (approximately 4 m/z) and CID
energy set to 20. Parent masses and fragment ions are listed in Tables S2
and S3.
In Vivo Detection of Cyclic Di-Nucleotides
WT and D131A/D133A mutant VC0179 were expressed in BL21 E. coli or
V. cholerae. Clarified cell supernatant was passed over a Waters Sep-Pak
C18 cartridge by gravity flow. Bound material was eluted, resuspended in
50% acetonitrile, and analyzed by LCMS as described.
Di-Nucleotide Cyclase Assay
A total of 50 nM of VC0179-63His or D131A/D133A mutant VC0179-63His
enzyme was incubated with the indicated NTPs at 37C for the indicated
time. Samples were processed for RP-HPLC, LCMS, MS/MS, or separated
by denaturing PAGE and exposed to film. The animal experiments were
performed with protocols approved by the Harvard Medical School Office
for Research Protection Standing Committee on Animals.
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